This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Genotropin® (somatropin, rbe) prescribing information and adverse event reporting can be found at the bottom of the page.

Turner Syndrome and short stature

Turner syndrome (TS) is a chromosomal disorder characterised by the complete or partial lack of one X chromosome in girls. The two most common clinical features are short stature and ovarian failure1.

Not all girls with Turner syndrome will need treatment with growth hormone, but if the condition is untreated when indicated, girls with Turner syndrome will have a final adult height of 136–147 cm which on average is 20 cm shorter than other adult women1.

Turner syndrome occurs in between 1 in 1500 and 1 in 2500 live female births1.

Turner Syndrome

Watch Dr Helen Turner talk about the early diagnosis of Turner syndrome, one of the most common chromosomal disorders in women

Clinical presentation2,3

  • The presentation of TS varies throughout a patient’s life2 and the clinical appearance itself is highly variable3
  • At any age, TS may be difficult to recognise clinically because physical manifestations can be subtle2

At birth​​​​​​​3

  • Congenital lymphoedema, low hairline, nuchal skin and webbed neck may be present
  • Other features include small jaw, higharched palate, ptosis, down-slanting palpebral fissures, epicanthal folds, midface hypoplasia, prominent ears, dysplastic nails, broad chest with hypoplastic nipples, cubitus valgus, multiple pigmented nevi and short fourth metacarpals

Children and adults3

  • Difficulties with recurrent otitis media may lead to conductive hearing loss, while sensorineural hearing loss of unknown aetiology is common in adults
  • Intelligence is within the normal range, although difficulties with visual–spatial organisation and attention deficit are common
  • Autoimmune disorders, especially thyroiditis and (to a lesser extent) coeliac disease, occur with sufficient frequency to warrant screening

Explore more

Genotropin efficacy & safety in Turner Syndrome patients

Learn more about how Genotropin can help your patients with Turner Syndrome on our Genotropin brand site

Learn more

Genotropin Homecare

Pfizer offers a range of homecare and patient support services to Genotropin patients

Learn more


References:

​​​​​​​1. NICE Guidance [TA188]. Human growth hormone (somatropin) for the treatment of growth failure in children.
2. Morgan T. Am Fam Physician 2007, 76: 405–10.
3. Pinhas-Hamiel O, Czernichow P, Zeitler P, Allen DB. Chapter 2: Normal growth and Growth Disorders. Pediatric Practice Endocrinology, 23–76.
PP-GEN-GBR-0906. March 2021

Paediatric Growth Hormone Deficiency

Learn more

NICE technology appraisal guidance

Find out more about NICE’s technology appraisals on the use of Genotropin on our Genotropin brand site

Find out more

The Genotropin Delivery Portfolio

Learn more about the 3 devices available for Genotropin patients on our Genotropin brand site

Learn more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No